# Effects of hepatic lipid ratio on lipid metabolism indices and hepatic gene expression in late-phase laying hens

**Authors:** Yongfeng Li, Xingguo Wang, Haibing Tong, Liang Qu, Dan Shao, Qiang Wang, Wei Guo, Jun Guo, Taocun Dou, Yuping Hu, Jian Lu, Meng Ma, Chungang Feng

PMC · DOI: 10.1016/j.psj.2026.106777 · 2026-03-13

## TL;DR

This study explores how liver fat accumulation affects metabolism and gene activity in aging hens, identifying key indicators and biological pathways involved.

## Contribution

The study identifies practical indicators and gene expression changes linked to hepatic lipid accumulation in aging laying hens.

## Key findings

- Hepatic lipid ratio strongly correlates with liver triglycerides and cholesterol in hens.
- Transcriptomic analysis reveals genes and pathways involved in lipid metabolism, inflammation, and antioxidant responses.
- Body weight and plasma lipid metrics are practical indicators of hepatic lipid deposition.

## Abstract

Alleviating hepatic lipid deposition in aging laying hens is critical for maintaining liver health and extending their productive lifespan. This study aimed to identify potential indicators and elucidate the underlying mechanisms associated with liver fat accumulation. Hepatic lipid ratio is a key indicator of the lipid deposition in the liver. A total of 509 healthy G1 line hens at 66 weeks of age were assessed for hepatic lipid ratio and stratified into three groups: low (L, <5%), medium (M, 5–10%), and high (H, >10%). The results revealed that the correlation coefficients of liver triglyceride (TG) and total cholesterol (TC) with the hepatic lipid ratio were 0.907 and 0.870, respectively, indicating a strong and highly significant association. All three metrics differed significantly among the three groups (P < 0.01), validating the grouping approach. Compared with the L group, the M and H groups showed significantly higher body weight, abdominal fat weight, abdominal fat index, plasma TG, TC, and LDL-c (P < 0.05), while plasma HDL-C was significantly lower in group H compared with groups L and M (P < 0.05). Abdominal skinfold thickness differed significantly across all groups (P < 0.05). Transcriptomic analysis revealed 115 up-regulated and 50 down-regulated genes in the H group compared with the L group. We identified: four genes (PCSK9, ABCG8, G6PC2, FOLH1) were associated with lipid metabolism; three (IL1RAPL1, TNIP2, HPSE2) with inflammatory response; five (CCL3, CCL17, CCL20, SAMSN1, ICOS) with immune response; and six (HBA1, HBAD, HBBA, CHAC1, CREG1, DDIT4) with antioxidant function. KEGG pathway analysis highlighted enrichments in lipid metabolism-related pathways such as “ABC transporters” and “Insulin secretion,” as well as in the inflammatory response-related pathway “Cytokine-cytokine receptor interaction.” In conclusion, body weight, abdominal skinfold thickness, plasma TG, TC, LDL-c, and HDL-c may serve as practical indicators for evaluating hepatic lipid deposition in laying hens. Excessive lipid accumulation perturbs hepatic metabolic homeostasis, triggering transcriptional reprogramming associated with both inflammatory and oxidative stress responses, alongside adaptive antioxidant defense and anti-inflammatory responses. However, further studies are required to determine whether these changes reflect a bona fide compensatory protective mechanism in the liver.

## Linked entities

- **Genes:** PCSK9 (proprotein convertase subtilisin/kexin type 9) [NCBI Gene 255738], ABCG8 (ATP binding cassette subfamily G member 8) [NCBI Gene 64241], G6PC2 (glucose-6-phosphatase catalytic subunit 2) [NCBI Gene 57818], FOLH1 (folate hydrolase 1) [NCBI Gene 2346], IL1RAPL1 (interleukin 1 receptor accessory protein like 1) [NCBI Gene 11141], TNIP2 (TNFAIP3 interacting protein 2) [NCBI Gene 79155], HPSE2 (heparanase 2 (inactive)) [NCBI Gene 60495], CCL3 (C-C motif chemokine ligand 3) [NCBI Gene 6348], CCL17 (C-C motif chemokine ligand 17) [NCBI Gene 6361], CCL20 (C-C motif chemokine ligand 20) [NCBI Gene 6364], SAMSN1 (SAM domain, SH3 domain and nuclear localization signals 1) [NCBI Gene 64092], ICOS (inducible T cell costimulator) [NCBI Gene 29851], HBA1 (hemoglobin subunit alpha 1) [NCBI Gene 3039], HBAD (hemoglobin alpha, subunit D) [NCBI Gene 416651], HBBA (hemoglobin subunit epsilon 1) [NCBI Gene 396485], CHAC1 (ChaC glutathione specific gamma-glutamylcyclotransferase 1) [NCBI Gene 79094], CREG1 (cellular repressor of E1A stimulated genes 1) [NCBI Gene 8804], DDIT4 (DNA damage inducible transcript 4) [NCBI Gene 54541]

## Full-text entities

- **Genes:** CHAC1 (ChaC glutathione specific gamma-glutamylcyclotransferase 1) [NCBI Gene 423209], ICOS (inducible T cell costimulator) [NCBI Gene 424105], HPSE2 (heparanase 2 (inactive)) [NCBI Gene 423834], PCSK9 (proprotein convertase subtilisin/kexin type 9) [NCBI Gene 424664], INS (insulin) [NCBI Gene 396145], HBA1 (hemoglobin subunit alpha 1) [NCBI Gene 416652] {aka HBAA, alpha-A-globin}, G6PC2 (glucose-6-phosphatase catalytic subunit 2) [NCBI Gene 424171], CCL17 (C-C motif chemokine ligand 17) [NCBI Gene 415652] {aka TARC}, FOLH1 (folate hydrolase 1) [NCBI Gene 419011], SAMSN1 (SAM domain, SH3 domain and nuclear localization signals 1) [NCBI Gene 418470], GPER1 (G protein-coupled estrogen receptor 1) [NCBI Gene 416457] {aka GPCR30, GPER, GPR30}, TNIP2 (TNFAIP3 interacting protein 2) [NCBI Gene 422884], COLEC12 (collectin subfamily member 12) [NCBI Gene 421061], CCL20 (C-C motif chemokine ligand 20) [NCBI Gene 395082] {aka MIP-3ALPHA, Mip-3a, SCYA20, chCCL20}, IL1RAPL1 (interleukin 1 receptor accessory protein like 1) [NCBI Gene 427993], HPSE (heparanase) [NCBI Gene 373981], HBAD (hemoglobin alpha, subunit D) [NCBI Gene 416651] {aka HBA2, HBM}, LDLR (low density lipoprotein receptor) [NCBI Gene 395103], ABCG8 (ATP binding cassette subfamily G member 8) [NCBI Gene 421402], IL10 (interleukin 10) [NCBI Gene 428264] {aka IL-10, interleukin-10}, CREG1 (cellular repressor of E1A stimulated genes 1) [NCBI Gene 768680], DDIT4 (DNA damage inducible transcript 4) [NCBI Gene 107053650], HBBA (hemoglobin subunit epsilon 1) [NCBI Gene 396485] {aka HBB-A, HBG2}
- **Diseases:** lipid metabolic disorders (MESH:D052439), hepatocyte injury (MESH:D014947), hepatic lipidosis (MESH:D008064), obesity (MESH:D009765), liver fat (MESH:D017093), lipid (MESH:D011017), liver diseases (MESH:D008107), Inflammatory (MESH:D007249), FLS (MESH:D005234), metabolic dysfunction (MESH:D008659), TG (MESH:C566031), Hypoxia (MESH:D000860), overweight (MESH:D050177)
- **Chemicals:** Fe (MESH:D007501), AP (MESH:D000667), Lipid (MESH:D008055), TG (MESH:D014280), biotin (MESH:D001710), genistein (MESH:D019833), Trizol (MESH:C411644), dexamethasone (MESH:D003907), cholesterol (MESH:D002784), vitamin B2 (MESH:D012256), CP (-), alanine (MESH:D000409), Mn (MESH:D008345), Ca (MESH:D002118), pantethine (MESH:C005425), I (MESH:D007455), cortisol (MESH:D006854), glutamine (MESH:D005973), fatty acid (MESH:D005227), oxygen (MESH:D010100), petroleum ether (MESH:C004544), betaine (MESH:D001622), nicotinic acid (MESH:D009525), aspartate (MESH:D001224), glucose-6-phosphate (MESH:D019298), glucose (MESH:D005947), nitrogen (MESH:D009584), tyrosine (MESH:D014443), Se (MESH:D012643), Cu (MESH:D003300), sterol (MESH:D013261), folic acid (MESH:D005492), reactive oxygen species (MESH:D017382), inorganic phosphate (MESH:D010710), amino acids (MESH:D000596), PBS (MESH:D007854), pantothenic acid (MESH:D010205), glutamate (MESH:D018698)
- **Species:** Gallus gallus (bantam, species) [taxon 9031]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13011204/full.md

---
Source: https://tomesphere.com/paper/PMC13011204